Dr. Arnauld VERSCHUUR is a pediatric oncologist at La Timone Children’s Hospital in Marseille. He is the coordinator of the Biology Committee of Innovative Therapies for Children with Cancer (ITCC) consortium, that aims at selecting novel compounds for the treatment of pediatric malignancies through a stepwise preclinical approach. Dr. VERSCHUUR is currently principal investigator of a French national phase 2 study “SFCE-Metro01” with a metronomic regimen of 4 compounds (vinblastine, celecoxib, cyclophosphamide and methotrexate) in recurrent/refractory pediatric solid tumours.